IE45993L - Immunotherapy of neoplastic disease. - Google Patents
Immunotherapy of neoplastic disease.Info
- Publication number
- IE45993L IE45993L IE772371A IE237177A IE45993L IE 45993 L IE45993 L IE 45993L IE 772371 A IE772371 A IE 772371A IE 237177 A IE237177 A IE 237177A IE 45993 L IE45993 L IE 45993L
- Authority
- IE
- Ireland
- Prior art keywords
- cells
- vaccine
- immunotherapy
- neoplastic disease
- cell components
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 238000009169 immunotherapy Methods 0.000 title abstract 2
- 230000001613 neoplastic effect Effects 0.000 title abstract 2
- 210000004027 cell Anatomy 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 210000003850 cellular structure Anatomy 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229920001282 polysaccharide Polymers 0.000 abstract 1
- 239000005017 polysaccharide Substances 0.000 abstract 1
- -1 polysaccharide carbohydrate Chemical class 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Oncology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A process for producing a vaccine for use in the immunotherapy of neoplastic disease, said vaccine being produced by: (a) obtaining an amount of cancerous tissue from the patient to be treated; (b) disaggregating the tissue into its component cells: (c) suspending the cells in water; (d) subjecting the suspended cells to hydrodynamic turbulence sufficient to disrupt the cells and detach therefrom the cell components possessing cancer-specific antigens; and (e) contacting and admixing the cell components obtained in step (d) with a source of mangenous ion and a macro-molecular polysaccharide carbohydrate to form the vaccine. [IN146800A1]
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74460176A | 1976-11-24 | 1976-11-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE45993L true IE45993L (en) | 1978-05-24 |
| IE45993B1 IE45993B1 (en) | 1983-01-26 |
Family
ID=24993313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2371/77A IE45993B1 (en) | 1976-11-24 | 1977-11-23 | Method of producing vaccine for the immunotherapy of neoplastic disease |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU511417B2 (en) |
| GB (1) | GB1592496A (en) |
| IE (1) | IE45993B1 (en) |
| IN (1) | IN146800B (en) |
| MX (1) | MX4306E (en) |
| NZ (1) | NZ185768A (en) |
| ZA (1) | ZA776822B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8321009D0 (en) * | 1983-08-04 | 1983-09-07 | New R R C | Immunological compositions |
| DE3432714A1 (en) * | 1984-09-06 | 1986-04-24 | Behringwerke Ag, 3550 Marburg | TUMOR THERAPEUTICS AND METHOD FOR THE PRODUCTION THEREOF |
-
1977
- 1977-11-15 ZA ZA00776822A patent/ZA776822B/en unknown
- 1977-11-17 IN IN396/DEL/77A patent/IN146800B/en unknown
- 1977-11-22 AU AU30822/77A patent/AU511417B2/en not_active Expired
- 1977-11-23 NZ NZ185768A patent/NZ185768A/en unknown
- 1977-11-23 IE IE2371/77A patent/IE45993B1/en not_active IP Right Cessation
- 1977-11-23 MX MX776575U patent/MX4306E/en unknown
- 1977-11-24 GB GB48910/77A patent/GB1592496A/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NZ185768A (en) | 1979-10-25 |
| MX4306E (en) | 1982-03-19 |
| GB1592496A (en) | 1981-07-08 |
| AU3082277A (en) | 1979-05-31 |
| IE45993B1 (en) | 1983-01-26 |
| AU511417B2 (en) | 1980-08-21 |
| IN146800B (en) | 1979-09-15 |
| ZA776822B (en) | 1979-06-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1322000A (en) | Preparation of antiserum specific for a carcinoembryonic antigen | |
| EP0057105A3 (en) | Method of producing alkali-soluble cellulose derivative | |
| DE3066566D1 (en) | Process for the immunological determination of basement membrane material, specific basement membrane fragments therefor and process for preparing or winning them | |
| IE46215L (en) | Gamma-globulins, immune nucleic acids and immune dialysates. | |
| ES457505A1 (en) | Tobacco products and methods for their preparation | |
| JPS5587724A (en) | Selective immune enhancer | |
| GB1049066A (en) | Improvements in the production of micro-organisms from hydrocarbons | |
| IE45993L (en) | Immunotherapy of neoplastic disease. | |
| ES8206855A1 (en) | Detection of human cancer cells with antibodies to human cancer cell nucleolar antigen(s) | |
| IE780974L (en) | Vaccine for immunotherapy of neoplastic disease | |
| SE8801426D0 (en) | METHOD AND METHOD OF BLOOD TREATMENT | |
| EP0317085A3 (en) | Processed red blood cells and process for producing the same | |
| ES474962A1 (en) | Coupled hydrocarbon polymers and process for their preparation. | |
| DE3272729D1 (en) | Hepatitis-a viruses adapted to human fibroblast cells | |
| GB2010089A (en) | Immunotherapeutic agent for treating cancer | |
| ES424506A1 (en) | Process for reducing sticking of blood cells to glass in blood testing procedures | |
| EP0257962A3 (en) | Method for treatment of peripheral blood to improve lymphokine activated killer immunotherapy | |
| JPS52113793A (en) | Cell dispersion method for cell inspection | |
| JPS5413286A (en) | Manufacture for subminiature crystal oscillator | |
| PT83368A (en) | Process for propagating microorganisms in vivo by using cell lines which lack human class ii histocompatibility antigens | |
| EP0103177A3 (en) | Separation of microbial polysaccharides as amine adducts, and their use | |
| IL67944A0 (en) | Antibodies and antigens useful in the diagnosis and treatment of cancer,methods for the production thereof and methods for testing for the presence of cancer cells using the same | |
| JPS546861A (en) | Dehydrating method for sludge | |
| JPS52125481A (en) | Water-dispersible absorbers for blood et al. | |
| FR2059561A1 (en) | Anti aphthic vaccine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK9A | Patent expired |